Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma

Table 3 Correlation analysis for immune checkpoints and programmed death 1/programmed death ligand 1/programmed death ligand 2

	PD-1 r	PD-1 padj	PD-L1 r	PD-L1 padj	PD-L2 r	PD-L2 padj
CD28	0.57465488	4.28 × 10-34	0.6660232	9.08 × 10-49	0.71414661	6.86 × 10-59
CD80	0.63623359	1.59 × 10-43	0.67510422	2.19 × 10-50	0.70070417	4.16 × 10-56
CD86	0.72311298	2.38 × 10-61	0.69521618	2.70 × 10-54	0.79715204	1.59 × 10-82
CTLA4	0.82827652	6.53 × 10-95	0.53400839	9.77 × 10-29	0.62325084	2.09 × 10-41
RGMB	0.08079832	0.11878686	0.31356282	5.62 × 10-10	0.15655839	0.00239497
CD58	0.4020193	6.49 × 10-16	0.44699953	1.00 × 10-19	0.34510312	7.46 × 10-12
CD27	0.8554091	2.51 × 10-107	0.564041	1.70 × 10-32	0.70361681	1.23 × 10-56
CD70	0.73757481	6.84 × 10-65	0.49791513	1.14 × 10-24	0.5810653	5.35 × 10-35
HLA-A	0.49005962	6.82 × 10-24	0.45628329	1.56 × 10-20	0.47535158	2.20 × 10-22
CD74	0.62377393	1.71 × 10-41	0.57693716	3.59 × 10-34	0.68544635	6.61 × 10-53

PD-1: Programmed death 1; PD-L1: Programmed death ligand 1; PD-L2: Programmed death ligand 2.